R Joss
University Hospital of Bern · 150 works · 3,093 citations · h-index 25
Top works
- A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
- A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
- Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer
- Role of radiation therapy in small cell anaplastic carcinoma of the lung.
- SUDDEN DEATH IN CANCER PATIENT ON HIGH-DOSE DOMPERIDONE
- New agents in non-small cell lung cancer
- A Phase I trial of Cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-schedule
- ?Fatigue and malaise? as a quality-of-life indicator in small-cell lung cancer patients
- Effect of thoracic radiotherapy on mortality in limited small cell lung cancer. A meta-analysis of 13 randomized trials among 2,140 patients.
- Cis‐dichlorodiammineplatinum (II) and VP 16–213 combination chemotherapy for non‐small cell lung cancer
- Hereditary persistence of α-fetoprotein
- Acute Cerebrovascular Accident after Treatment with Cis-Platinum and Methylprednisolone
- A randomized comparison of doxifluridine and fluorouracil in colorectal carcinoma
- [Central nervous system metastases in small cell lung cancer].
- Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung
- Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer association of antitumor activity with initial tumor burden and treatment center
- Neuropharmacology of emesis and its relevance to anti-emetic therapy
- Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy
- Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC)
- The symptomatic control of cytostatic drug-induced emesis. A recent history and review.